Dr. Eric Mininberg, MD

Expert Publications

• Effect of inhibition of ornithine decarboxylase activity in a model of acute hepatocellular necrosis.

Media Releases

Get to know Oncologist Dr. Eric Mininberg, who serves patients throughout the State of Georgia.

A leader in the field of medical oncology, Dr. Mininberg diagnoses and treats patients with all cancer types. He joined Piedmont Cancer Institute in 2003 and now serves as the President. He currently sees patients at their offices in Atlanta and Stockbridge, Georgia.

The physicians and advanced practitioners at Piedmont Cancer Institute work closely with patients’ entire treatment team of specialists, primary care physicians, family, and caregivers to address their individualized cancer treatment plan. They integrate leading-edge therapies, the latest clinical trials, and cancer wellness programs for the best care possible.

Throughout his academic career, Dr. Mininberg graduated with his medical degree from the University of Virginia School of Medicine, and completed his residency in internal medicine at the same educational venue. He then went on to complete his fellowship in hematology at Baylor University, and his fellowship in medical oncology at the University of Texas MD Anderson Cancer Center.

In pursuit of clinical excellence, the doctor is board-certified in medical oncology, hematology, and internal medicine by the American Board of Internal Medicine (ABIM). The ABIM is a physician-led, non-profit, independent evaluation organization driven by doctors who want to achieve higher standards for better care in a rapidly changing world.

Oncology is a branch of medicine that deals with the prevention, diagnosis, and treatment of cancer. A medical professional who practices oncology is an oncologist. An oncologist is a doctor who treats cancer and provides medical care for a person diagnosed with cancer. They lead a cancer treatment team of various healthcare professionals, treat patients with radiation therapy, coordinate treatment plans and prescribe various types of treatment, including chemotherapy and immunotherapy, as well as assist patients with pain management.

A recipient of numerous awards and honors, Dr. Mininberg was inducted as a member of the Cum Laude Society with St. Albans School in Washington, DC in 1989. While at The University of Texas MD Anderson Cancer Center, he was honored with the Elsa U. Pardee Foundation Grant for Community Oncology. As a fellow in 2003, he was awarded the American Society of Clinical Oncology Merit Award.

Happily married, he and his wife have two children. In his free time, he enjoys cooking and playing with his large friendly rescue retriever mix, Nickel.

Recommended Articles

• Can Multiple Myeloma be Asymptomatic?

  Early treatment for persons suffering from multiple myeloma that is asymptomatic may not be beneficial. The initial stages for multiple myeloma do not show symptoms, and this is known as being asymptomatic.The treatment for persons with asymptomatic multiple myeloma should be deferred up to when the...

• Breaking News on the Treatment of Follicular Lymphoma

  Reuters, the international news agency out of London, has announced that the FDA has given a new drug “accelerated approval,” for the treatment of follicular lymphoma.The drug, Aliqopa (copanlisib), showed complete or partial shrinkage of tumors in 59% of study participants during drug studies,...

• New Study Discovers How Lymphoma Affects Survivors’ Ability to Work

  Young adults in many countries pride themselves on their work. They have worked hard to get to where they are and there is a huge sense of accomplishment in joining the adult world and being able to provide for themselves and their new families if applicable. When cancer comes along, their ability...

• The Lymphoma Research Foundation's Light it Red for Lymphoma Night

  Lymphoma, a cancer of the lymphatic system, currently affects over 700,000 Americans who are living with or in remission from the disease. Statistics show that every seven minutes, someone in the United States is diagnosed with the condition, which amounts to approximately 80,000 people per year.The...

• AstraZeneca Gains United States Approval for Lymphoma Drug

  Some forms of lymphoma are rarer than others. Most people can recognize Hodgkin lymphoma, but mantle cell lymphoma will strike them as a surprise.Because it is so rare, there are not as many drugs specific to this form of cancer. One has recently been approved in the United States, by the Food and...

• What Are Lymphocytes?

  A lymphocyte is a type of white blood cell (WBC) that has a significant function in the body's immune system. Lymphocytes function by properly responding to infectious microorganisms and other foreign invaders in the body. Lymphocytes can work alone, but some of them are also capable of...